Clinical pharmacology of beta-receptor-blocking drugs.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001775:Blood Circulation / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004336:Drug Antagonism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism; D000860:Hypoxia; D007328:Insulin / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects; D011802:Quinidine / Q000494:pharmacology; D012146:Rest; D013565:Sympatholytics / Q000378:metabolism / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D013565:Sympatholytics; D013566:Sympathomimetics; D013006:Growth Hormone; D011802:Quinidine